PortfoliosLab logoPortfoliosLab logo
IBCA vs. PCRB
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IBCA vs. PCRB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares iBonds Dec 2035 Term Corporate ETF (IBCA) and Putnam ESG Core Bond ETF - (PCRB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IBCA achieves a 0.20% return, which is significantly higher than PCRB's -0.32% return.


IBCA

1D
-0.27%
1M
0.37%
YTD
0.20%
6M
0.04%
1Y
6.55%
3Y*
5Y*
10Y*

PCRB

1D
-0.13%
1M
-0.22%
YTD
-0.32%
6M
-0.43%
1Y
4.53%
3Y*
4.09%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

IBCA vs. PCRB - Yearly Performance Comparison


Correlation

The correlation between IBCA and PCRB is 0.90, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.90

Correlation (All Time)
Calculated using the full available price history since Mar 27, 2025

0.87

The correlation between IBCA and PCRB has been stable across timeframes, ranging from 0.87 to 0.90 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IBCA vs. PCRB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBCA
IBCA Risk / Return Rank: 3939
Overall Rank
IBCA Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
IBCA Sortino Ratio Rank: 3939
Sortino Ratio Rank
IBCA Omega Ratio Rank: 3636
Omega Ratio Rank
IBCA Calmar Ratio Rank: 4343
Calmar Ratio Rank
IBCA Martin Ratio Rank: 4242
Martin Ratio Rank

PCRB
PCRB Risk / Return Rank: 3333
Overall Rank
PCRB Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
PCRB Sortino Ratio Rank: 3535
Sortino Ratio Rank
PCRB Omega Ratio Rank: 3131
Omega Ratio Rank
PCRB Calmar Ratio Rank: 3131
Calmar Ratio Rank
PCRB Martin Ratio Rank: 3333
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBCA vs. PCRB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares iBonds Dec 2035 Term Corporate ETF (IBCA) and Putnam ESG Core Bond ETF - (PCRB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IBCAPCRBDifference
Sharpe ratioReturn per unit of total volatility

+0.12

Sortino ratioReturn per unit of downside risk

+0.13

Omega ratioGain probability vs. loss probability

1.23

1.21

+0.02

Calmar ratioReturn relative to maximum drawdown

2.07

1.51

+0.56

Martin ratioReturn relative to average drawdown

6.57

4.90

+1.66

IBCA vs. PCRB - Sharpe Ratio Comparison

The current IBCA Sharpe Ratio is 1.33, which is comparable to the PCRB Sharpe Ratio of 1.21. The chart below compares the historical Sharpe Ratios of IBCA and PCRB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IBCAPCRBDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.33

1.21

+0.12

Sharpe Ratio (All Time)

Calculated using the full available price history

1.08

0.59

+0.49

Drawdowns

IBCA vs. PCRB - Drawdown Comparison

The maximum IBCA drawdown since its inception was -3.48%, smaller than the maximum PCRB drawdown of -7.20%. Use the drawdown chart below to compare losses from any high point for IBCA and PCRB.


Loading charts...

Drawdown Indicators


IBCAPCRBDifference

Max Drawdown

Largest peak-to-trough decline

-3.48%

-7.20%

+3.72%

Max Drawdown (1Y)

Largest decline over 1 year

-3.19%

-3.02%

-0.17%

Max Drawdown (3Y)

Largest decline over 3 years

-5.85%

Current Drawdown

Current decline from peak

-1.42%

-2.18%

+0.76%

Average Drawdown

Average peak-to-trough decline

-0.81%

-1.64%

+0.83%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.00%

0.93%

+0.07%

Volatility

IBCA vs. PCRB - Volatility Comparison

iShares iBonds Dec 2035 Term Corporate ETF (IBCA) has a higher volatility of 1.62% compared to Putnam ESG Core Bond ETF - (PCRB) at 1.32%. This indicates that IBCA's price experiences larger fluctuations and is considered to be riskier than PCRB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IBCAPCRBDifference

Volatility (1M)

Calculated over the trailing 1-month period

1.62%

1.32%

+0.30%

Volatility (6M)

Calculated over the trailing 6-month period

3.62%

2.66%

+0.96%

Volatility (1Y)

Calculated over the trailing 1-year period

4.96%

3.77%

+1.19%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

5.76%

5.63%

+0.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

5.76%

5.63%

+0.13%

IBCA vs. PCRB - Expense Ratio Comparison

IBCA has a 0.10% expense ratio, which is lower than PCRB's 0.35% expense ratio.


Dividends

IBCA vs. PCRB - Dividend Comparison

IBCA's dividend yield for the trailing twelve months is around 4.67%, less than PCRB's 9.79% yield.


PositionTTM202520242023
IBCA
iShares iBonds Dec 2035 Term Corporate ETF
4.67%3.19%0.00%0.00%
PCRB
Putnam ESG Core Bond ETF -
9.79%4.30%4.38%3.65%

Frequently Asked Questions


IBCA and PCRB have a correlation of 0.90, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IBCA has higher volatility (1.62%) compared to PCRB (1.32%). In terms of maximum drawdown, IBCA dropped -3.48% vs PCRB's -7.20%.

On 1-year performance, IBCA leads with 6.55% vs 4.53% for PCRB. On fees, IBCA is cheaper at 0.10% per year. On volatility, PCRB has been the lower-risk option at 1.32%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, IBCA has performed better with a 6.55% return vs 4.53%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IBCA is cheaper with a 0.10% expense ratio, compared with 0.35% for PCRB.

PCRB has the higher dividend yield at 9.79%, compared with 4.67% for IBCA.

They also come from different issuers: iShares and Putnam. Their fees differ too: 0.10% for IBCA and 0.35% for PCRB.

IBCA currently has the higher Sharpe Ratio (1.33 vs 1.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IBCA and PCRB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer